home / stock / femy / femy quote
Last: | $1.27 |
---|---|
Change Percent: | 0.0% |
Open: | $1.29 |
Close: | $1.27 |
High: | $1.29 |
Low: | $1.24 |
Volume: | 258,021 |
Last Trade Date Time: | 05/17/2024 03:00:00 am |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.27 | $1.29 | $1.27 | $1.29 | $1.24 | 258,021 | 05-17-2024 |
$1.29 | $1.32 | $1.29 | $1.36 | $1.26 | 138,866 | 05-16-2024 |
$1.33 | $1.35 | $1.33 | $1.39 | $1.32 | 117,303 | 05-15-2024 |
$1.38 | $1.28 | $1.38 | $1.38 | $1.25 | 180,889 | 05-14-2024 |
$1.27 | $1.24 | $1.27 | $1.3 | $1.21 | 182,457 | 05-13-2024 |
$1.21 | $1.28 | $1.21 | $1.285 | $1.2 | 139,097 | 05-10-2024 |
$1.27 | $1.34 | $1.27 | $1.3742 | $1.25 | 235,599 | 05-09-2024 |
$1.39 | $1.43 | $1.39 | $1.51 | $1.37 | 302,352 | 05-08-2024 |
$1.42 | $1.39 | $1.42 | $1.44 | $1.34 | 138,488 | 05-07-2024 |
$1.35 | $1.3 | $1.35 | $1.39 | $1.3 | 180,326 | 05-06-2024 |
$1.29 | $1.28 | $1.29 | $1.32 | $1.24 | 62,923 | 05-03-2024 |
$1.235 | $1.29 | $1.235 | $1.3299 | $1.22 | 284,746 | 05-02-2024 |
$1.3 | $1.27 | $1.3 | $1.34 | $1.27 | 108,399 | 05-01-2024 |
$1.27 | $1.33 | $1.27 | $1.33 | $1.27 | 69,173 | 04-30-2024 |
$1.32 | $1.27 | $1.32 | $1.34 | $1.25 | 84,220 | 04-29-2024 |
$1.27 | $1.33 | $1.27 | $1.3643 | $1.21 | 138,216 | 04-26-2024 |
$1.33 | $1.33 | $1.33 | $1.34 | $1.27 | 103,654 | 04-25-2024 |
$1.33 | $1.34 | $1.33 | $1.41 | $1.32 | 114,142 | 04-24-2024 |
$1.33 | $1.23 | $1.33 | $1.36 | $1.23 | 280,799 | 04-23-2024 |
$1.27 | $1.32 | $1.27 | $1.355 | $1.22 | 224,046 | 04-22-2024 |
News, Short Squeeze, Breakout and More Instantly...
Femasys Inc. Company Name:
FEMY Stock Symbol:
NASDAQ Market:
ATLANTA, May 17, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, announces CEO and Founder K...
ATLANTA, May 16, 2024 (GLOBE NEWSWIRE) -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical company focused on addressing significant unmet needs of women worldwide with a broad portfolio of in-office, accessible, and innovative therapeutic and diagnostic products, announces CEO and Found...